Hippocampus neuronal metabolic gene expression outperforms whole tissue data in accurately predicting Alzheimer's disease progression

Neurobiology of Aging

Volumn 33, Issue 9, 2012, Pages 2230.e13-2230.e21

  Stempler, Shiri ^a   Waldman, Yedael Y ^a   Wolf, Lior ^a   Ruppin, Eytan ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Alzheimer's disease; Classification model; Gene expression; Hippocampus; Metabolism; Mini Mental State Examination (MMSE); Neuron; Regression

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; GENE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE LOCATION; GENETIC ASSOCIATION; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; MINI MENTAL STATE EXAMINATION; MTHFR GENE; PREDICTION; PRIORITY JOURNAL; TISSUE MICROARRAY;

EID: 84863486610     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2012.04.003     Document Type: Article

References (46)

1. Barnham K.J., Masters C.L., Bush A.I. Neurodegenerative diseases and oxidative stress. Nat. Rev. Drug Discov 2004, 3:205-214.
2. Bertram L., McQueen M.B., Mullin K., Blacker D., Tanzi R.E. Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat. Genet 2007, 39:17-23.
3. Blalock E.M., Geddes J.W., Chen K.C., Porter N.M., Markesbery W.R., Landfield P.W. Incipient Alzheimer's disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses. Proc. Natl. Acad. Sci. U. S. A 2004, 101:2173-2178.
4. Blass J.P. Brain metabolism and brain disease: is metabolic deficiency the proximate cause of Alzheimer dementia?. J. Neurosci. Res 2001, 66:851-856.
5. Bonda D.J., Wang X., Perry G., Nunomura A., Tabaton M., Zhu X., Smith M.A. Oxidative stress in Alzheimer disease: a possibility for prevention. Neuropharmacology 2010, 59:290-294.
6. Bossers K., Meerhoff G., Balesar R., van Dongen J.W., Kruse C.G., Swaab D.F., Verhaagen J. Analysis of gene expression in Parkinson's disease: possible involvement of neurotrophic support and axon guidance in dopaminergic cell death. Brain Pathol 2009, 19:91-107.
7. Breiman L. Random forests. Mach. Learn 2001, 45:5-32.
8. Butterfield D.A., Hardas S.S., Lange M.L. Oxidatively modified glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and Alzheimer's disease: many pathways to neurodegeneration. J. Alzheimers Dis 2010, 20:369-393.
9. Chandrasekaran K., Giordano T., Brady D.R., Stoll J., Martin L.J., Rapoport S.I. Impairment in mitochondrial cytochrome oxidase gene expression in Alzheimer disease. Brain Res. Mol. Brain Res 1994, 24:336-340.
10. Clark C.M., Sheppard L., Fillenbaum G.G., Galasko D., Morris J.C., Koss E., Mohs R., Heyman A. Variability in annual Mini-Mental State Examination score in patients with probable Alzheimer disease: a clinical perspective of data from the Consortium to Establish a Registry for Alzheimer's Disease. Arch. Neurol 1999, 56:857-862.
11. Crow T.J. A theory of the evolutionary origins of psychosis. Eur. Neuropsychopharmacol 1995, 5(suppl):59-63.
12. Duarte N.C., Becker S.A., Jamshidi N., Thiele I., Mo M.L., Vo T.D., Srivas R., Palsson B.O. Global reconstruction of the human metabolic network based on genomic and bibliomic data. Proc. Natl. Acad. Sci. U. S. A 2007, 104:1777-1782.
13. Ferrer I. Altered mitochondria, energy metabolism, voltage-dependent anion channel, and lipid rafts converge to exhaust neurons in Alzheimer's disease. J. Bioenerg. Biomembr 2009, 41:425-431.
14. Finch C.E., Sapolsky R.M. The evolution of Alzheimer disease, the reproductive schedule, and apoE isoforms. Neurobiol. Aging 1999, 20:407-428.
15. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res 1975, 12:189-198.
16. Fu X., Giavalisco P., Liu X., Catchpole G., Fu N., Ning Z.B., Guo S., Yan Z., Somel M., Pääbo S., Zeng R., Willmitzer L., Khaitovich P. Rapid metabolic evolution in human prefrontal cortex. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:6181-6186.
17. Gibson G.E., Ratan R.R., Beal M.F. Mitochondria and oxidative stress in neurodegenerative disorders. Preface. Ann. N. Y. Acad. Sci. 2008, 1147:xi-xii.
18. Ginsberg S.D., Alldred M.J., Che S. Gene expression levels assessed by CA1 pyramidal neuron and regional hippocampal dissections in Alzheimer's disease. Neurobiol. Dis 2012, 45:99-107.
19. Hinkle D.A., Eberwine J.H. Single-cell molecular biology: implications for diagnosis and treatment of neurologic disease. Biol. Psychiatry 2003, 54:413-417.
20. Ho G.J., Hashimoto M., Adame A., Izu M., Alford M.F., Thal L.J., Hansen L.A., Masliah E. Altered p59Fyn kinase expression accompanies disease progression in Alzheimer's disease: implications for its functional role. Neurobiol. Aging 2005, 26:625-635.
21. Johnson G.V., Bailey C.D. Tau, where are we now?. J. Alzheimers Dis 2002, 4:375-398.
22. Kamme F., Salunga R., Yu J., Tran D.T., Zhu J., Luo L., Bittner A., Guo H.Q., Miller N., Wan J., Erlander M. Single-cell microarray analysis in hippocampus CA1: demonstration and validation of cellular heterogeneity. J. Neurosci 2003, 23:3607-3615.
23. Kennedy B.P., Bottiglieri T., Arning E., Ziegler M.G., Hansen L.A., Masliah E. Elevated S-adenosylhomocysteine in Alzheimer brain: influence on methyltransferases and cognitive function. J. Neural Transm 2004, 111:547-567.
24. Khaitovich P., Lockstone H.E., Wayland M.T., Tsang T.M., Jayatilaka S.D., Guo A.J., Zhou J., Somel M., Harris L.W., Holmes E., Pääbo S., Bahn S. Metabolic changes in schizophrenia and human brain evolution. Genome Biol 2008, 9:R124.
25. Khaitovich P., Tang K., Franz H., Kelso J., Hellmann I., Enard W., Lachmann M., Pääbo S. Positive selection on gene expression in the human brain. Curr. Biol. 2006, 16:R356-R358.
26. Kim J.M., Stewart R., Kim S.W., Yang S.J., Shin I.S., Shin H.Y., Yoon J.S. Methylenetetrahydrofolate reductase gene and risk of Alzheimer's disease in Koreans. Int. J. Geriatr. Psychiatry 2008, 23:454-459.
27. Li K., Liu S., Yao S., Wang B., Dai D., Yao L. Interaction between interleukin-8 and methylenetetrahydrofolate reductase genes modulates Alzheimer's disease risk. Dement. Geriatr. Cogn. Disord 2009, 27:286-291.
28. Liang W.S., Dunckley T., Beach T.G., Grover A., Mastroeni D., Ramsey K., Caselli R.J., Kukull W.A., McKeel D., Morris J.C., Hulette C.M., Schmechel D., Reiman E.M., Rogers J., Stephan D.A. Neuronal gene expression in non-demented individuals with intermediate Alzheimer's Disease neuropathology. Neurobiol. Aging 2010, 31:549-566.
29. Liang W.S., Reiman E.M., Valla J., Dunckley T., Beach T.G., Grover A., Niedzielko T.L., Schneider L.E., Mastroeni D., Caselli R., Kukull W., Morris J.C., Hulette C.M., Schmechel D., Rogers J., Stephan D.A. Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons. Proc. Natl. Acad. Sci. U. S. A 2008, 105:4441-4446.
30. Masters C.L., Simms G., Weinman N.A., Multhaup G., McDonald B.L., Beyreuther K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl. Acad. Sci. U. S. A 1985, 82:4245-4249.
31. Mattson M.P. Pathways towards and away from Alzheimer's disease. Nature 2004, 430:631-639.
32. Mihaescu R., Detmar S.B., Cornel M.C., van der Flier W.M., Heutink P., Hol E.M., Rikkert M.G., van Duijn C.M., Janssens A.C. Translational research in genomics of Alzheimer's disease: a review of current practice and future perspectives. J. Alzheimers Dis 2010, 20:967-980.
33. Parkinson H., Sarkans U., Kolesnikov N., Abeygunawardena N., Burdett T., Dylag M., Emam I., Farne A., Hastings E., Holloway E., Kurbatova N., Lukk M., Malone J., Mani R., Pilicheva E., Rustici G., Sharma A., Williams E., Adamusiak T., Brandizi M., Sklyar N., Brazma A. ArrayExpress update-an archive of microarray and high-throughput sequencing-based functional genomics experiments. Nucleic Acids Res 2011, 39(Database issue):D1002-D1004.
34. Radmacher M.D., McShane L.M., Simon R. A paradigm for class prediction using gene expression profiles. J. Comput. Biol 2002, 9:505-511.
35. Ray M., Zhang W. Integrating gene expression and phenotypic information to analyze Alzheimer's disease. J. Alzheimers Dis 2009, 16:73-84.
36. Reed T., Perluigi M., Sultana R., Pierce W.M., Klein J.B., Turner D.M., Coccia R., Markesbery W.R., Butterfield D.A. Redox proteomic identification of 4-hydroxy-2-nonenal-modified brain proteins in amnestic mild cognitive impairment: insight into the role of lipid peroxidation in the progression and pathogenesis of Alzheimer's disease. Neurobiol. Dis 2008, 30:107-120.
37. Su A.I., Wiltshire T., Batalov S., Lapp H., Ching K.A., Block D., Zhang J., Soden R., Hayakawa M., Kreiman G., Cooke M.P., Walker J.R., Hogenesch J.B. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc. Natl. Acad. Sci. U. S. A 2004, 101:6062-6067.
38. Su B., Wang X., Zheng L., Perry G., Smith M.A., Zhu X. Abnormal mitochondrial dynamics and neurodegenerative diseases. Biochim. Biophys. Acta 2010, 1802:135-142.
39. Sultana R., Boyd-Kimball D., Poon H.F., Cai J., Pierce W.M., Klein J.B., Merchant M., Markesbery W.R., Butterfield D.A. Redox proteomics identification of oxidized proteins in Alzheimer's disease hippocampus and cerebellum: an approach to understand pathological and biochemical alterations in AD. Neurobiol. Aging 2006, 27:1564-1576.
40. Terry R.D., Gonatas N.K., Weiss M. Ultrastructural studies in Alzheimer's presenile dementia. Am. J. Pathol 1964, 44:269-297.
41. Vernace V.A., Schmidt-Glenewinkel T., Figueiredo-Pereira M.E. Aging and regulated protein degradation: who has the UPPer hand?. Aging Cell 2007, 6:599-606.
42. Waldman Y.Y., Tuller T., Shlomi T., Sharan R., Ruppin E. Translation efficiency in humans: tissue specificity, global optimization and differences between developmental stages. Nucleic Acids Res 2010, 38:2964-2974.
43. Wang B., Jin F., Kan R., Ji S., Zhang C., Lu Z., Zheng C., Yang Z., Wang L. Association of MTHFR gene polymorphism C677T with susceptibility to late-onset Alzheimer's disease. J. Mol. Neurosci 2005, 27:23-27.
44. Wang X., Su B., Zheng L., Perry G., Smith M.A., Zhu X. The role of abnormal mitochondrial dynamics in the pathogenesis of Alzheimer's disease. J. Neurochem 2009, 109(suppl 1):153-159.
45. Webster J.A., Gibbs J.R., Clarke J., Ray M., Zhang W., Holmans P., Rohrer K., Zhao A., Marlowe L., Kaleem M., McCorquodale D.S., Cuello C., Leung D., Bryden L., Nath P., Zismann V.L., Joshipura K., Huentelman M.J., Hu-Lince D., Coon K.D., Craig D.W., Pearson J.V., Heward C.B., Reiman E.M., Stephan D., Hardy J., Myers A.J. Genetic control of human brain transcript expression in Alzheimer disease. Am. J. Hum. Genet 2009, 84:445-458.
46. Zhu X., Perry G., Moreira P.I., Aliev G., Cash A.D., Hirai K., Smith M.A. Mitochondrial abnormalities and oxidative imbalance in Alzheimer disease. J. Alzheimers Dis 2006, 9:147-153.